Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
US Department of Justice
Mallinckrodt
Merck
Moodys
Cantor Fitzgerald
Fish and Richardson
Express Scripts
Johnson and Johnson
Farmers Insurance

Generated: January 17, 2018

DrugPatentWatch Database Preview

Rubicon Res Pvt Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for RUBICON RES PVT LTD, and what generic and branded alternatives to RUBICON RES PVT LTD drugs are available?

RUBICON RES PVT LTD has three approved drugs.

There is one tentative approval on RUBICON RES PVT LTD drugs.

Summary for Rubicon Res Pvt Ltd
US Patents:0
Tradenames:3
Ingredients:3
NDAs:3

Drugs and US Patents for Rubicon Res Pvt Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rubicon Res Pvt Ltd CYCLOBENZAPRINE HYDROCHLORIDE cyclobenzaprine hydrochloride TABLET;ORAL 208170-001 May 31, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Rubicon Res Pvt Ltd SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 204883-001 Jun 20, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Rubicon Res Pvt Ltd METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 200981-001 Oct 28, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Rubicon Res Pvt Ltd CYCLOBENZAPRINE HYDROCHLORIDE cyclobenzaprine hydrochloride TABLET;ORAL 208170-002 May 31, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Rubicon Res Pvt Ltd METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 200981-002 Oct 28, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Rubicon Res Pvt Ltd METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 200981-003 Oct 28, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Rubicon Res Pvt Ltd CYCLOBENZAPRINE HYDROCHLORIDE cyclobenzaprine hydrochloride TABLET;ORAL 208170-003 May 31, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Novartis
Julphar
Citi
US Department of Justice
Moodys
Chubb
Merck
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot